Hope for simple cancer test

A simple blood test might help to identify patients developing cancer at an early stage, British researchers say.

The Bradford University researchers say they have come up with "remarkable" findings.

The test measures the strength of the immune system – identifying when it is under stress caused by the onset of cancer.

According to the researchers, the test takes white blood cells and exposes them to ultra-violet light, which can damage DNA.

They say that white blood cells are more susceptible to DNA damage when they are under stress from cancer or pre-cancerous conditions.

So far they have conducted trials involving samples of blood from patients with melanoma, colon cancer and lung cancer. Some 208 people took part in the testing.

The researchers have now revealed their findings in the FASEB Journal. Further clinical trials are under way at Bradford Royal Infirmary.

Researcher Professor Diana Anderson said: “These are early results completed on three different types of cancer and we accept that more research needs to be done; but these results so far are remarkable.

“Whilst the numbers of people we tested are, in epidemiological terms, quite small, in molecular epidemiological terms, the results are powerful."

Diana Anderson et al. Sensitivity and Specificity of the Empirical Lymphocyte Genome Sensitivity (LGS) Assay: Implications for Improving Cancer Diagnostics. FASEB Journal 28 July 2014; FJ 14-254748.

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index